skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: AVEO Oncology share price jumped after it got FDA approval for
FOTIVDA® (tivozanib) around 2 months ago. It ramped up for this by securing capital, and issued new equity, @ $ 8.00 which was fully subscribed, including all offered additional shares. New Director appointed who seems to be quite an authority on cancer research.

Unfortunately. the Share price dropped after the spike on approval, and has fallen back to old levels. what seems to be the problem ? When do you think, if at all, the price will reach the lofty levels recommended by the Analysts covering it.

Thanks and Appreciate all the advise and guidance you and your team provides.

Rajesh
Read Answer Asked by Rajesh on May 13, 2021
Q: My understanding is that shareholders of PHO will receive$3.60 per share if the buyout goes through. is there any reason to hold onto Pho right now given that the buyout is for $3.60 and this is what other traders seem to be willing to pay right now? there were a lot of asks vs bids today. I'm not sure why someone would want to buy Pho knowing that the maximum they will receive is $3.60. can you please shed some light on this?
thanks for your help
Read Answer Asked by Mary on May 13, 2021
Q: Hi.
I own DND. I was pleased with the results and later today(May 12th) they announced a small acquisition in the UK.
Looking at the industry they operating in and the services they provide, DND seems to have an economic moat. They can raise their prices and companies using them will not have much of a choice but to agree due to very limited competition. This is a very powerful position for a company to be in which allows it to protect its market share and profitability and to keep growing. Do you agree with my thesis?
Thanks
Read Answer Asked by ilie on May 13, 2021
Q: Hi Team,
As a growth investor my stock portfolio is about 75% high growth tech weighted (mostly US) and has now fallen 25% or so from peak during this rotation. I have so far been hesitant to trim or sell anything up to this point. Is it time to bite the bullet and cash out part of my holdings and buy into other sectors that favour inflation? Or do you think the damage is near done here and possibly start adding to beat down quality growth names? Right now the sky is falling for my type of portfolio and trying to decide which way to go. Or perhaps just do nothing...
Thanks
Shane
Read Answer Asked by Shane on May 13, 2021
Q: I am currently looking to rebalance my portfolio taking into account the latest volitilty. I am a long term investor and fairly well diversified. I do need to top up in a few places. Would you suggest your favourite stocks in each of the following sectors: energy, health, telecom and industrials.
Thanks Peter and all of you for this wonderful service.
Read Answer Asked by Cathy on May 12, 2021
Q: Please rate these cyber security companies as your choice to buy for a 3-5 yr. hold. Any others you would choose?
Read Answer Asked by Terry on May 12, 2021
Q: To my amateur eyes, it looks to me that XIT has reached a major support level of around $43 (looking at technical support and resistance levels). I hold a core long term position and did some trimming for asset allocation reasons around $50. I would normally consider adding at this level, but thought I'd check with you (again) about the impact of interest rates on technology. Do you see much more technology downside in your crystal ball?

Thanks for your help...Steve
Read Answer Asked by Stephen on May 12, 2021
Q: why would inflation take down gsy by 14 and doo by 10 as i write this.
in addition i thought gsys earnings were fantastic.
some inflation is good and year over year comparisons make no sense because of pandemic.
can you comment
dave
Read Answer Asked by david on May 12, 2021
Q: Please recommend some CAD etfs to play commodities. Is there one that covers a broad selection?
Read Answer Asked by Patrick on May 12, 2021
Q: Is there anything apparently wrong with this company or just current market sentiment?
April 2 you felt there was "still a lot of good news priced in". It's dropped a lot further since then with a PE under 18x but a PB of around 13x.
How do you feel about its price now? What do you think is a reasonable PB range for this company?
Read Answer Asked by Peter on May 12, 2021
Q: In your opinion, is the rise in the CAD overdone at these levels?
Read Answer Asked by Albert on May 12, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!